OLMA

$10.51+$0.07 (+0.67%)live

Compare

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institution

Market cap

$913.5M

87M shares

52-week range

$5.15 – $36.26

17% from low

Sector

PHARMACEUTICAL PREPARATIONS

Exchange

NASDAQ

Change$-15.65

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$2M	—	$-2.21	$-2.31–$-2.14	—	7
2027	$23M	+927.7%	$-2.40	$-2.76–$-2.23	—	7
2028	$132M	+472.4%	$-1.85	$-2.79–$-1.00	—	4
2029	$295M	+122.7%	$-1.09	$-1.96–$-0.49	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Earnings surprises

Beat consensus in 4 of the last 8 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-08-10	$-0.55	$-0.61	-10.6%
2026-05-12	$-0.52	$-0.52	+0.0%
2026-03-16	$-0.51	$-0.50	+2.0%
2025-11-10	$-0.44	$-0.49	-11.4%
2025-08-11	$-0.43	$-0.51	-18.6%
2025-05-13	$-0.49	$-0.36	+26.5%
2025-03-18	$-0.63	$-0.51	+19.0%
2024-11-12	$-0.59

DCF fair valuemodel estimate

Intrinsic value

$0.49

Price

$10.51

Implied downside

-95%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
OLMAOlema Pharmaceuticals, Inc.	$10.51	+0.67%	$918M	—
ABSIAbsci Corporation	$9.46	-0.42%	$1.6B	—
CRVSCorvus Pharmaceuticals, Inc.	$15.14	+0.60%	$1.3B	—
FDMT4D Molecular Therapeutics, Inc.	$11.65	-1.85%	$609M	—
GOSSGossamer Bio, Inc.	$0.17	-4.11%

Olema Pharmaceuticals, Inc. Common Stock

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

www.olema.com

Employees: 150
IPO / List date: Nov 19, 2020
HQ: SAN FRANCISCO, CA

Held by traders on TradeandTell

No one on the platform currently holds OLMA.

Super investors & insiders

Institutions holding (13F)

Institution	Shares	Reported
Renaissance Technologiesas of 2025-12-31	25,067	$626.7K

Insider activity (SEC Form 4)

Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded OLMA yet.

$OLMA chatter on StockTwits

Anachart@anachartanalyst10h
$OLMA https://anachart.com/wp-content/uploads/2026/08/1786651321_soc-img.jpg
View on StockTwits ↗
Mark Wise@Asterix_le_Gaulois2d
$OLMA is the main reason for the fall the delay of Opera-01 read out from this fall to next year?
View on StockTwits ↗
Jr.@Rodmon77Bullish2d
$OLMA Nice Buying Opportunity Mixed Earnings
View on StockTwits ↗